Ronald Li

Chief Executive Officer at Medera Biopharmaceutical

Boston, Massachusetts, United States

About

Experience

  • Chief Executive Officer at Medera Biopharmaceutical
    Jan 2021 - Present · 5 yrs 6 mos

  • Chief Scientific Officer at Sardocor
    Jul 2020 - Present · 6 yrs

  • Founder & Executive Director at Xellera Therapeutics
    2018 - Present · 8 yrs 6 mos

  • CEO & Interim Chief R&D Officer at Novoheart
    2016 - Present · 10 yrs 6 mos

    NVH on Toronto Stock Exchange (TSXV) 3NH on Frankfurt Stock Exchange

  • Court Member at The Hong Kong Polytechnic University
    2021 - Present · 5 yrs 6 mos